Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tiagabine for the Treatment of Cocaine Dependence in Methadone-Maintained Individuals

NCT00129298 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00129298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00129298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tiagabine for the Treatment of Cocaine Dependence in Methadone-Maintained Individuals
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
April 30, 2007
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine-related disorders, opiate dependence